Sage Therapeutics, Inc.

CAMBRIDGE, MA How do I update this listing?

Sage Therapeutics is based out of Cambridge. Sage Therapeutics, Inc. develops treatments for central nervous system disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions.Whalewisdom has at least 130 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2021-01-15. The notice included securities offered of Equity

Create Alert

Contact Info

sage therapeutics, inc.
215 FIRST STREET
CAMBRIDGE MA    02142

Business Phone: 617-299-8380
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2021-01-15 D PHARMACEUTICALS Equity 649,986,998 649,986,998 0
2014-03-24 D OTHER HEALTH CARE Equity 38,000,000 38,000,000 0
2014-01-21 D OTHER HEALTH CARE Equity 20,000,000 10,000,000 10,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALBERT J. ROBICHAUD subscription required
    EXECUTIVE OFFICER
ANNE MARIE COOK subscription required
    EXECUTIVE OFFICER
BARRY GREENE subscription required
    EXECUTIVE OFFICER DIRECTOR
ELIZABETH BARRETT subscription required
    DIRECTOR
GENO GERMANO subscription required
    DIRECTOR
GEORGE GOLUMBESKI subscription required
    DIRECTOR
JAMES F. FRATES subscription required
    DIRECTOR
JEFFERY M. JONAS subscription required
    EXECUTIVE OFFICER DIRECTOR
JEFFREY M. JONAS subscription required
    EXECUTIVE OFFICER DIRECTOR
KEVIN STARR subscription required
    DIRECTOR
KIMI IGUCHI subscription required
    EXECUTIVE OFFICER
MICHAEL CLOONAN subscription required
    EXECUTIVE OFFICER
MICHAEL F. COLA subscription required
    DIRECTOR
ROBERT T. NELSEN subscription required
    DIRECTOR
STEPHEN J. KANES subscription required
    EXECUTIVE OFFICER
STEVEN PAUL subscription required
    DIRECTOR

Elevate your investments